Translation of amnion stem cells to the clinic

Stem Cells and Development

Volumn 22, Issue SUPPL.1, 2013, Pages 96-102

  Strom, Stephen C ^a   Skvorak, Kristen ^b   Gramignoli, Roberto ^a   Marongiu, Fabio ^c   Miki, Toshio ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LIVER FAILURE; AMNION CELL; AMNION EPITHELIAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL THERAPY; EPITHELIUM CELL; GOOD MANUFACTURING PRACTICE; HUMAN; LIVER CELL; LIVER DISEASE; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; STEM CELL; STEM CELL TRANSPLANTATION;

AMNION; CELL- AND TISSUE-BASED THERAPY; HEPATOCYTES; HUMANS; LIVER DISEASES; LIVER FAILURE, ACUTE; STEM CELL TRANSPLANTATION; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84890919764     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0391     Document Type: Article

References (53)

1. Baraniak PR and TC McDevitt. (2010). Stem cell paracrine actions and tissue regeneration. Regen Med 5:121-143.
2. Jackson WM, LJ Nesti and RS Tuan. (2012). Mesenchymal stem cell therapy for attenuation of scar formation during wound healing. Stem Cell Res Ther 3:20.
3. Pederiva F, M Ghionzoli, A Pierro, P De Coppi and JA Tovar. (2013). Amniotic fluid stem cells rescue both in vitro and in vivo growth, innervation, and motility in nitrofen-exposed hypoplastic rat lungs through paracrine effects. Cell Transplant 22:1683-1694.
4. Yu J and JA Thomson. (2008). Pluripotent stem cell lines. Genes Dev 22:1987-1997.
5. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fi broblast cultures by defi ned factors. Cell 126:663-676.
6. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
7. Miki T, T Lehmann, H Cai, DB Stolz and SC Strom. (2005). Stem cell characteristics of amniotic epithelial cells. Stem Cells 23:1549-1559.
8. Lee AS, C Tang, MS Rao, IL Weissman and JC Wu. (2013). Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med 19:998-1004.
9. Strauss S. (2010). Geron trial resumes, but standards for stem cell trials remain elusive. Nat Biotechnol 28:989-990.
10. Schwartz SD, JP Hubschman, G Heilwell, V Franco-Cardenas, CK Pan, RM Ostrick, E Mickunas, R Gay, I Klimanskaya and R Lanza. (2012). Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 379:713-720.
11. Cyranoski D. (2013). Stem cells cruise to clinic. Nature 494:413.
12. Franquesa M, MJ Hoogduijn, ME Reinders, E Eggenhofer, AU Engela, FK Mensah, J Torras, A Pileggi, C van Kooten, B Mahon, O Detry, FC Popp, V Benseler, F Casiraghi, C Johnson, J Ancans, B Fillenberg, O Delarosa, JM Aran, M Roemeling-Vanrhijn, J Pinxteren, N Perico, E Gotti, B Christ, J Reading, M Introna, R Deans, M Shagidulin, R Farre, A Rambaldi, A Sanchez-Fueyo, N Obermajer, A Pulin, FJ Dor, I Portero-Sanchez, CC Baan, TJ Rabelink, G Remuzzi, MG Betjes, MH Dahlke and JM Grinyo. (2013). Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting: Lessons learned from first clinical trials. Transplantation 96:234-238.
13. Groth CG, B Arborgh, C Bjorken, B Sundberg and G Lundgren. (1977). Correction of hyperbilirubinemia in the glucuronyltransferase-defi cient rat by intraportal hepatocyte transplantation. Transplant Proc 9:313-316.
14. Gupta S, PR Yerneni, RP Vemuru, CD Lee, EL Yellin and KK Bhargava. (1993). Studies on the safety of intrasplenic hepatocyte transplantation: Relevance to ex vivo gene therapy and liver repopulation in acute hepatic failure. Hum Gene Ther 4:249-257.
15. Rozga J, M Holzman, AD Moscioni, H Fujioka, E Morsiani and AA Demetriou. (1995). Repeated intraportal hepatocyte transplantation in analbuminemic rats. Cell Transplant 4:237-243.
16. Gupta S, H Malhi, S Gagandeep and P Novikoff. (1999). Liver repopulation with hepatocyte transplantation: New avenues for gene and cell therapy. J Gene Med 1:386-392.
17. Gupta S, P Rajvanshi, AN Irani, CJ Palestro and KK Bhargava. (2000). Integration and proliferation of transplanted cells in hepatic parenchyma following D-galactosamine-induced acute injury in F344 rats. J Pathol 190:203-210.
18. Ohashi K, F Park and MA Kay. (2001). Hepatocyte transplantation: Clinical and experimental application. J Mol Med 79:617-630.
19. Strom SC, JR Chowdhury and IJ Fox. (1999). Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 19:39-48.
20. Strom SC, RA Fisher, MT Thompson, AJ Sanyal, PE Cole, JM Ham and MP Posner. (1997). Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 63:559-569.
21. Strom SC, RA Fisher, WS Rubinstein, JA Barranger, RB Towbin, M Charron, L Mieles, LA Pisarov, K Dorko, MT Thompson and J Reyes. (1997). Transplantation of human hepatocytes. Transplant Proc 29:2103-2106.
22. Fox IJ, JR Chowdhury, SS Kaufman, TC Goertzen, NR Chowdhury, PI Warkentin, K Dorko, BV Sauter and SC Strom. (1998). Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 338:1422-1426.
23. Horslen SP, TC McCowan, TC Goertzen, PI Warkentin, HB Cai, SC Strom and IJ Fox. (2003). Isolated hepatocyte transplantation in an infant with a severe urea cycle disorder. Pediatrics 111:1262-1267.
24. Jorns C, EC Ellis, G Nowak, B Fischler, A Nemeth, SC Strom and BG Ericzon. (2012). Hepatocyte transplantation for inherited metabolic diseases of the liver. J Intern Med 272:201-223.
25. Soltys KA, A Soto-Gutierrez, M Nagaya, KM Baskin, M Deutsch, R Ito, BL Shneider, R Squires, J Vockley, C Guha, J Roy-Chowdhury, SC Strom, JL Platt and IJ Fox. (2010). Barriers to the successful treatment of liver disease by hepatocyte transplantation. Hepatology 53:769-774.
26. Puppi J, SC Strom, RD Hughes, S Bansal, JV Castell, I Dagher, EC Ellis, G Nowak, BG Ericzon, IJ Fox, MJ Gomez-Lechon, C Guha, S Gupta, RR Mitry, K Ohashi, M Ott, LM Reid, J Roy-Chowdhury, E Sokal, A Weber and A Dhawan. (2012). Improving the techniques for human hepatocyte transplantation: Report from a consensus meeting in London. Cell Transplant 21:1-10.
27. Miki T, F Marongiu, EC Ellis, K Dorko, K Mitamura, A Ranade, R Gramignoli, J Davila and SC Strom. (2009). Production of hepatocyte-like cells from human amnion. Methods Mol Biol 481:155-168.
28. Yeager AM, HS Singer, JR Buck, R Matalon, S Brennan, SO O'Toole and HW Moser. (1985). A therapeutic trial of amniotic epithelial cell implantation in patients with lysosomal storage diseases. Am J Med Genet 22:347-355.
29. Scaggiante B, A Pineschi, M Sustersich, M Andolina, E Agosti and D Romeo. (1987). Successful therapy of Niemann-Pick disease by implantation of human amniotic membrane. Transplantation 44:59-61.
30. Sakuragawa N, H Yoshikawa and M Sasaki. (1992). Amniotic tissue transplantation: Clinical and biochemical evaluations for some lysosomal storage diseases. Brain Dev 14:7-11.
31. Takahashi N, S Enosawa, T Mitani, H Lu, S Suzuki, H Amemiya, T Amano and N Sakuragawa. (2002). Transplantation of amniotic epithelial cells into fetal rat liver by in utero manipulation. Cell Transplant 11:443-449.
32. Manuelpillai U, J Tchongue, D Lourensz, V Vaghjiani, CS Samuel, A Liu, ED Williams and W Sievert. (2010). Transplantation of human amnion epithelial cells reduces hepatic fi brosis in immunocompetent CCl(4)-Treated mice. Cell Transplant 19:1157-1168.
33. Sant'Anna LB, A Cargnoni, L Ressel, G Vanosi and O Parolini. (2011). Amniotic membrane application reduces liver fi brosis in a bile duct ligation rat model. Cell Transplant 20:441-453.
34. Marongiu F, R Gramignoli, K Dorko, T Miki, AR Ranade, M Paola Serra, S Doratiotto, M Sini, S Sharma, K Mitamura, TL Sellaro, V Tahan, KJ Skvorak, EC Ellis, SF Badylak, JC Davila, R Hines, E Laconi and SC Strom. (2011). Hepatic differentiation of amniotic epithelial cells. Hepatology 53:1719-1729.
35. Skvorak KJ, HS Paul, K Dorko, F Marongiu, E Ellis, D Chace, C Ferguson, KM Gibson, GE Homanics and SC Strom. (2009). Hepatocyte transplantation improves phenotype and extends survival in a murine model of intermediate maple syrup urine disease. Mol Ther 17:1266-1273.
36. Skvorak KJ, EJ Hager, E Arning, T Bottiglieri, HS Paul, SC Strom, GE Homanics, Q Sun, EE Jansen, C Jakobs, WJ Zinnanti and KM Gibson. (2009). Hepatocyte transplantation (HTx) corrects selected neurometabolic abnormalities in murine intermediate maple syrup urine disease (iMSUD). Biochim Biophys Acta 1792:1004-1010.
37. Skvorak KJ, K Dorko, F Marongiu, V Tahan, MC Hansel, R Gramignoli, KM Gibson and SC Strom. (2013). Placental stem cell correction of murine intermediate maple syrup urine disease. Hepatology 57:1017-1023.
38. Skvorak KJ, K Dorko, F Marongiu, V Tahan, MC Hansel, R Gramignoli, E Arning, T Bottiglieri, KM Gibson and SC Strom. (2013). Improved amino acid, bioenergetic metabolite and neurotransmitter profi les following human amnion epithelial cell transplant in intermediate maple syrup urine disease mice. Mol Genet Metab 109:132-138.
39. Bailo M, M Soncini, E Vertua, PB Signoroni, S Sanzone, G Lombardi, D Arienti, F Calamani, D Zatti, P Paul, A Albertini, F Zorzi, A Cavagnini, F Candotti, GS Wengler and O Parolini. (2004). Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78:1439-1448.
40. Hori J, M Wang, K Kamiya, H Takahashi and N Sakuragawa. (2006). Immunological characteristics of amniotic epithelium. Cornea 25:S53-S58.
41. Kamiya K, M Wang, S Uchida, S Amano, T Oshika, N Sakuragawa and J Hori. (2005). Topical application of culture supernatant from human amniotic epithelial cells suppresses inflammatory reactions in cornea. Exp Eye Res 80:671-679.
42. Li H, JY Niederkorn, S Neelam, E Mayhew, RA Word, JP McCulley and H Alizadeh. (2005). Immunosuppressive fac tors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci 46:900-907.
43. Ueta M, MN Kweon, Y Sano, C Sotozono, J Yamada, N Koizumi, H Kiyono and S Kinoshita. (2002). Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clin Exp Immunol 129:464-470.
44. Wolbank S, A Peterbauer, M Fahrner, S Hennerbichler, M van Griensven, G Stadler, H Redl and C Gabriel. (2007). Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: A comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13:1173-1183.
45. Lefebvre S, F Adrian, P Moreau, L Gourand, J Dausset, S Berrih-Aknin, ED Carosella and P Paul. (2000). Modulation of HLA-G expression in human thymic and amniotic epithelial cells. Hum Immunol 61:1095-1101.
46. Hammer A, H Hutter, A Blaschitz, W Mahnert, M Hartmann, B Uchanska-Ziegler, A Ziegler and G Dohr. (1997). Amnion epithelial cells, in contrast to trophoblast cells, express all classical HLA class I molecules together with HLA-G. Am J Reprod Immunol 37:161-171.
47. Houlihan JM, PA Biro, HM Harper, HJ Jenkinson and CH Holmes. (1995). The human amnion is a site of MHC class Ib expression: Evidence for the expression of HLA-E and HLA-G. J Immunol 154:5665-5674.
48. Fisher RA and SC Strom. (2006). Human hepatocyte transplantation: Worldwide results. Transplantation 82:441-449.
49. Ott M, A Schneider, M Attaran and MP Manns. (2006). [Transplantation of hepatocytes in liver failure]. Dtsch Med Wochenschr 131:888-891.
50. Banas RA, C Trumpower, C Bentlejewski, V Marshall, G Sing and A Zeevi. (2008). Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells. Hum Immunol 69:321-328.
51. Manuelpillai U, Y Moodley, CV Borlongan and O Parolini. (2011). Amniotic membrane and amniotic cells: Potential therapeutic tools to combat tissue inflammation and fi brosis ? Placenta 32 Suppl 4:S320-S325.
52. Vosdoganes P, RJ Hodges, R Lim, AJ Westover, RY Acharya, EM Wallace and TJ Moss. (2011). Human amnion epithelial cells as a treatment for inflammation-induced fetal lung injury in sheep. Am J Obstet Gynecol 205:156.e26-e33.
53. Li J, L Zhang, J Xin, L Jiang, T Zhang, L Jin, P Zhou, S Hao, H Cao and L Li. (2012). Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs. Hepatology 56:1044-1052.